AstraZeneca and Thermo Fisher Partner to Match Patients to Precision Therapies

AstraZeneca and Thermo Fisher Scientific announced a multi-year strategic collaboration to co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx). The partnership will leverage Thermo Fisher’s technology and expertise to inform AstraZeneca’s extensive portfolio of targeted medicines.